sdbn.org

A wise man once said that overnight success in biotech takes about 15 years. All kidding aside, we at Xconomy recognize that real innovation in life sciences doesn’t just pop out of the blue on...

[[Click headline to continue reading.]] More...

Isis Pharmaceuticals (NASDAQ: ISIS), the Carlsbad, CA-based biotech company, said today it has earned a $6 million payment from Bristol-Myers Squibb for getting clearance from regulators to begin...

[[Click headline to continue reading.]] More...

Scientists in San Diego and Hayward, CA, have demonstrated the feasibility of using algae to produce commercial levels of human therapeutic proteins that are currently being used to treat emphysema...

[[Click headline to continue reading.]] More...

HIV has taught the pharmaceutical industry that the best way to fight an infectious virus that resists a single drug is to make a cocktail that attacks the virus in more than one way. Vertex...

[[Click headline to continue reading.]] More...

[Updated: 4:05 pm Eastern, 3/5/10, with company comment] San Diego will have to wait a while longer for another biotech IPO. Trius Therapeutics, the San Diego-based developer of an antibiotic against...

[[Click headline to continue reading.]] More...

Some 800,000 people in the U.S. are diagnosed each year with obstructive sleep apnea, in which the tongue relaxes during the onset of sleep to the point of physically blocking much of the upper...

[[Click headline to continue reading.]] More...

Life Technologies (NASDAQ: LIFE) the Carlsbad, CA-based maker of gene sequencing instruments and lab supplies, said today it is joining an effort with two partners to sequence the genomes of 14 women...

[[Click headline to continue reading.]] More...

Neurocrine Biosciences, the San Diego biotech company developing treatments for neurological and endocrine disorders, said today it has raised gross proceeds of about $20 million in a stock offering....

[[Click headline to continue reading.]] More...

Two San Diego biotechs, Adamis Pharmaceuticals and La Jolla Pharmaceutical, said today they have agreed to terminate their merger agreement, which was signed three months ago. The Nasdaq market also...

[[Click headline to continue reading.]] More...

The La Jolla Research & Innovation Summit held yesterday at the Salk Institute was a smaller and a much more modest affair than the inaugural summit that Connect CEO Duane Roth organized last...

[[Click headline to continue reading.]] More...